Array Biopharma Inc $4.12

up +0.05


29/7/2014 09:59 AM  |  NASDAQ : ARRY  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get ARRY Trend Analysis - it has underperformed the S&P 500 by 53%

Partner Headlines

  1. Pepsi Beats; Positive Phase 3 Breast Cancer Data Creates Potential Buyout ...

    Benzinga
  2. Intuitive Surgical Rises On Upbeat Earnings; Xilinx Shares Slip

    Benzinga
  3. Markets Mixed; PepsiCo Q2 Earnings Beat Street View

    Benzinga
  4. Events Scheduled for Week of Jun. 16th to Jun. 20th

    Benzinga
  5. Array Biopharma Announces Binimetinib Continues to Advance in Clinical ...

    Benzinga
  6. Benzinga's Top #PreMarket Losers

    Benzinga
  7. Morning Gainers for Mar. 3, 2014: DNDN, PERI, RVNC, ARRY, OMEX, NIHD

    Benzinga
  8. Oncothyreon and Array BioPharma Announce Initiation of Phase 1b Trial of ...

    Benzinga
  9. Array BioPharma Issues Update on ARRY-614 for Myelodysplastic Syndromes ...

    Benzinga
  10. Array BioPharma Issues Update on ARRY-520 for Multiple Myeloma at '13 ASHM

    Benzinga
  11. Pharmaceutical Industry Expected To Collect Billions From Obamacare

    Benzinga
  12. These ETFs House The Next Biotech Takeover Targets

    Benzinga
  13. Benzinga's Top Pre-Market Losers

    Benzinga
  14. Array BioPharma Provides Updates On Clinical Data At The 2012 American ...

    Benzinga
  15. John Orwin Joins Array BioPharma Board Of Directors

    Benzinga
  16. Array BioPharma Inc. Reports Operating Results (10-Q)

    GuruFocus
  17. Array BioPharma CEO Favors Open, Unbiased Questions

    IBD
  18. Singles Only: 3 Low-Priced Stocks for Your Portfolio

    SchaeffersResearch
  19. Array Announces Changes to Board

    Benzinga
  20. Array BioPharma Inc. Reports Operating Results (10-K)

    GuruFocus
  21. Polypore International, True Religion Apparel Among Stocks Gapping Down ...

    FoxBusiness
  22. Health Care Sector Wrap

    FoxBusiness
  23. Array BioPharma Achieves $8.5 Million Clinical Milestone in Amgen Diabetes ...

    Benzinga
  24. Clovis Oncology and Array BioPharma Announce Agreement to Discover Novel ...

    Benzinga
  25. MEK162 Shows Promising Clinical Activity in Ongoing Phase 2 Trial

    Benzinga
  26. Highs & Lows: Array BioPharma, NII Holdings, and MEMC Electronic Materials

    SchaeffersResearch
  27. Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,545 Shares

    GuruFocus
  28. Array BioPharma Announces Proposed Public Offering of 20M Shares

    Benzinga
  29. Benzinga's Top Pre-Market Losers

    Benzinga
  30. Array BioPharma Inc. Reports Operating Results (10-Q)

    GuruFocus
  31. Array BioPharma Names Gwen A. Fyfe, M.D. to Board of Directors

    Benzinga
  32. From Earlier: Array BioPharma's Chief Executive Officer Robert E. Conway ...

    Benzinga
  33. Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,994 Shares

    GuruFocus
  34. Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,743 Shares

    GuruFocus
Trading Center